Vimarsana
Biggest News Aggregation in the World

Page 31 - Robert Read News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Read. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Read Today - Breaking & Trending Today

iTWire - MedAdvisor closes $5.25 million capital raising - Vimarsana News

iTWire - MedAdvisor closes $5.25 million capital raising

iTWire Friday, 07 May 2021 11:14 MedAdvisor closes $5.25 million capital raising Shares Robert Read, MedAdvisor CEO and Managing Director Australian-listed medtech company, MedAdvisor has closed a $5.25m capital raise via a placement, with the funds to be used to accelerate US growth initiatives. MedAdvisor (ASX: MDR) says it expects to pass $55 million in revenue this calendar year and the funds raised will also help drive the business towards cash flow breakeven. The equity raise was done at 30 cents per share, representing a 7.1% premium to the last traded price of Med...

Source: itwire.com
Human challenge models to advance vaccines against respiratory pathogens - Vimarsana News

Human challenge models to advance vaccines against respiratory pathogens

Human challenge models to advance vaccines against respiratory pathogens World Immunisation Week 2021 To mark World Immunisation Week 2021 from 24 to 30 April, the London School of Hygiene & Tropical Medicine (LSHTM) Vaccine Centre is hosting a series of webinars. The theme this year is ‘Vaccines Bring Us Closer’. Each day of the week we focus on an important area of vaccine research, science and debate bringing together experts in the field. We end the week with the Vaccine Centre Annual Lecture on 30 April.  In this event, we focus on the use of controlled h...

Covid vaccine side effects: What are they, who gets them and why? - Vimarsana News

Covid vaccine side effects: What are they, who gets them and why?

The AstraZeneca and Pfizer jabs both have side effects, but experts say most are mild and brief

HUMAN LAB RATS: UK to infect volunteers with coronavirus in world's first human challenge trial - Vimarsana News

HUMAN LAB RATS: UK to infect volunteers with coronavirus in world's first human challenge trial

The trial will involve up to 90 healthy adults aged 18–30 years who will be exposed to the original strain of the coronavirus in a safe, controlled environment to understand how the virus grows, as well as the early stages of infection before symptoms appear. The challenge trial involves a consortium that includes researchers from  Imperial College London, Royal Free London NHS Foundation Trust, the government’s vaccines taskforce and the clinical company hVIVO. Volunteers will be required to undergo extensive screening, which will include blood tests, imaging tests, heart scans an...

UK approves study that will deliberately infect volunteers with coronavirus - Vimarsana News

UK approves study that will deliberately infect volunteers with coronavirus

UK approves study that will deliberately infect volunteers with coronavirus